Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
H. Luo
ResearcherPublications, citations & collaboration network
H. Luo is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 3 works, 8 citations, an h-index of 1 and an i10-index of 0.
3
Works
8
Citations
1
h-index
0
i10-index
IDs:OpenAlex
How has H. Luo's publication output changed over time?
ScholarIQpublication output · 2025–2026
Output declined50% over the shown period — from 2 works in 2025 to 1 in 2026.
2
1
20252026
What are the most-cited papers on H. Luo?
ScholarIQmost cited works
Artificial intelligence-based personalized treatment strategies for unresectable hepatocellular carcinoma: integrating HSP90α for prognosis and survival prediction
Ke Su, X. Johné Liu, Xuelian Wang, Yunwei Han, H. Luo, Lianbin Wen, Jian Chen, Han Li, Susu Xiao, Jianwen Zhang, Chenjie Wang, Yuhang Zhou, Zunyuan Tan, Lexin Wang, P. Wang, Haiqing Chen, Guixu Zhang, Kun He, Xiaosong Li, Hao Chi, Zhenjiang Li, Ke Xu
npj Digital Medicine. 20258 CitationsOPEN ACCESS
490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial
B. Wang, D. Ye, H. Guo, L. Li, Suneel Mundle, F. Shen, Anildeep Singh, Y. Liu, Xiaoyu Jia, L. Han, N. Chen, H. Luo
Annals of Oncology. 20250 Citations
Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies
Li Zhang, Qihua Zhang, Xueliang Zhang, Aihong Mao, Yuhua Liu, H. Luo
MedComm – Future Medicine. 20260 CitationsOPEN ACCESS
Related on ScholarIQ
Sun Yat-sen University
Institution
Artificial intelligence-based personalized treatment strategies for unresectable hepatocellular carcinoma: integrating HSP90α for prognosis and survival prediction
Paper
490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial
Paper
Immunotherapy in Advanced Gastric Cancer: Advancing Precision Medicine and Emerging Therapeutic Strategies
Paper
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Cancer Immunotherapy and Biomarkers
Topic